Table 1 Demographics and ocular characteristics of the study population
Variables | Tafluprost-treated eyes (33 eyes of 20 patients) | Post-surgery eyes (38 eyes of 22 patients) | p-value |
|---|---|---|---|
Age [years] | 65.9 ± 11.9 | 70.3 ± 6.6 | 0.09 * |
Gender (male/female) | 23/10 | 27/11 | 0.90 † |
IOP [mmHg] | 14.2 ± 0.5 | 13.6 ± 0.4 | 0.33 ‡ |
SAP MD [dB] | − 4.4 ± 6.8 | −5.3 ± 3.8 | 0.48 ‡ |
SAP defect location (superior/inferior), n | 6/9 | 15/13 | |
SAP defect location (central), n | 6 | 9 | |
Average RNFLT [μm] | 82.3 ± 17.2 | 74.7 ± 20.2 | 0.11 ‡ |
HRT cup/disc area ratio | 0.40 ± 0.15 | 0.43 ± 0.18 | 0.56 ‡ |